MLI Stock Overview
Mesa Laboratories, Inc. develops, manufactures, and sells life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 4/6 |
| Past Performance | 1/6 |
| Financial Health | 1/6 |
| Dividends | 0/6 |
Mesa Laboratories, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$108.00 |
| 52 Week High | US$146.00 |
| 52 Week Low | US$77.50 |
| Beta | 0.82 |
| 1 Month Change | 10.77% |
| 3 Month Change | 26.32% |
| 1 Year Change | -25.52% |
| 3 Year Change | -46.53% |
| 5 Year Change | n/a |
| Change since IPO | -41.62% |
Recent News & Updates
Recent updates
Shareholder Returns
| MLI | DE Life Sciences | DE Market | |
|---|---|---|---|
| 7D | 2.9% | 0.3% | 2.5% |
| 1Y | -25.5% | -11.5% | 6.0% |
Return vs Industry: MLI underperformed the German Life Sciences industry which returned -11.7% over the past year.
Return vs Market: MLI underperformed the German Market which returned 5.4% over the past year.
Price Volatility
| MLI volatility | |
|---|---|
| MLI Average Weekly Movement | 6.6% |
| Life Sciences Industry Average Movement | 6.1% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in DE Market | 10.4% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: MLI has not had significant price volatility in the past 3 months.
Volatility Over Time: MLI's weekly volatility (7%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1982 | 698 | Gary Owens | www.mesalabs.com |
Mesa Laboratories, Inc. develops, manufactures, and sells life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally. It operates in four segments: Clinical Genomics, Sterilization and Disinfection Control, Biopharmaceutical Development, and Calibration Solutions. The Clinical Genomics segment develops, manufactures, and sells genetic analysis tools that include MassARRAY system and consumables, including chips, panels, and chemical reagent solutions used by clinical labs to perform genomic clinical testing in various therapeutic areas, such as screenings for hereditary diseases, pharmacogenetics, and oncology related applications.
Mesa Laboratories, Inc. Fundamentals Summary
| MLI fundamental statistics | |
|---|---|
| Market cap | €586.34m |
| Earnings (TTM) | €879.93k |
| Revenue (TTM) | €197.59m |
660.3x
P/E Ratio2.9x
P/S RatioIs MLI overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| MLI income statement (TTM) | |
|---|---|
| Revenue | US$212.87m |
| Cost of Revenue | US$82.57m |
| Gross Profit | US$130.31m |
| Other Expenses | US$129.36m |
| Earnings | US$948.00k |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
May 24, 2024
| Earnings per share (EPS) | 0.18 |
| Gross Margin | 61.21% |
| Net Profit Margin | 0.45% |
| Debt/Equity Ratio | 57.8% |
How did MLI perform over the long term?
See historical performance and comparisonDividends
0.6%
Current Dividend Yield363%
Payout RatioDoes MLI pay a reliable dividends?
See MLI dividend history and benchmarks| Mesa Laboratories dividend dates | |
|---|---|
| Ex Dividend Date | May 31 2024 |
| Dividend Pay Date | Jun 14 2024 |
| Days until Ex dividend | 20 days |
| Days until Dividend pay date | 34 days |
Does MLI pay a reliable dividends?
See MLI dividend history and benchmarks